Skip to content

Ultragenyx Pharmaceutical Inc.

RARE Nasdaq SEC CIK 1515673

Follow Ultragenyx Pharmaceutical Weekly email: filings, results, news

News

2 stories filed under Ultragenyx Pharmaceutical

Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?

Markets 30 d ago

Tactical Resources Completes Business Combination with Plum Acquisition Corp. III and Prepares for Nasdaq Listing

Deals 41 d ago 2 sources also on TREO III

Next results

NOV4

Q2 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: NOVATO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 2 stories clustered from the RSS aggregator